Africa's Medical Device Market to Surge by US$2.68 Billion – Why Now Is the Strategic Window for Global Suppliers

The African medical devices market is entering a period of accelerated expansion that global suppliers cannot afford to ignore. According to Technavio's latest analysis published in March 2026, the market is projected to increase by US$2.68 billion between 2025 and 2030, at a compound annual growth rate of 8.1%. The hospitals and clinics segment alone was valued at US$4.05 billion in 2024, making it the dominant demand driver across the continent.

What Is Fueling This Growth?

The market expansion is driven by a dual burden of infectious and chronic diseases, which creates sustained demand for products ranging from basic sterile hypodermic syringes to sophisticated interventional cardiology devices. Escalating healthcare expenditure and substantial infrastructure development are the two core pillars supporting this trajectory.

Public and private healthcare expenditure is fueling the establishment of new facilities that require modern patient monitoring equipment. Private hospitals, serving an expanding insured population, are procuring advanced technologies, while the public sector focuses on high-volume, cost-effective solutions such as infusion pumps and IV sets. The in-vitro diagnostics segment accounted for the largest market revenue share in 2024

Import Dependence Remains Structurally HighDespite growing local manufacturing ambitions, Africa still imports approximately 95% of its medical devices, primarily from China, the United States, Germany, and France. The Africa medical hygiene devices market, valued for infection control and sterile environments, is projected to grow at a CAGR of 6–8% from 2026 to 2035, with import dependence at 70–80% of total supply.

South Africa and Kenya serve as primary entry points for international manufacturers and distributors into the broader African market.

Key Trends Shaping Procurement

Public-sector tenders are increasingly specifying ISO 13485 or equivalent quality certification, shifting procurement away from uncertified low-cost imports toward regulated suppliers. Local assembly and finishing operations are emerging in Nigeria and Ethiopia, supported by government incentives and import substitution policies. Donor-funded programs for HIV, TB, and maternal health create predictable multi-year demand for specific device categories.

What This Means for Exporters

The convergence of rapid market growth, high import dependence, and tightening quality standards presents a clear opportunity for well-prepared medical device exporters. Success requires understanding diverse regional needs, navigating complex regulatory environments, and providing comprehensive after-sales support. A one-stop foreign trade service provider can bridge these gaps – from market research and product selection to registration, logistics, and local distribution.